Such patients include those with high levels of PPIX,22, 38 those with XLEPP, those with the homozygous form of EPP1,15 those exposed to additional hepatotoxic factors or those with a family history of protoporphyria‐related liver disease. This evidence concerns the gene FECH and X-linked erythropoietic protoporphyria.